Nutriband receives notice of allowance for u.s. patent covering transdermal abuse deterrent technology

Orlando, fl / accesswire / june 23, 2023 / nutriband inc. (nasdaq:ntrb)(nasdaq:ntrbw), a developer of transdermal pharmaceutical products, today announced that it received a notice of allowance from the united states patent and trademark office (uspto) on june 15, 2023 for patent application 17/568,999, "abuse and misuse deterrent transdermal systems" which covers its aversa™ abuse deterrent technology. the receipt of a notice of allowance means that the uspto is expected to issue a u.s. patent for this application after administrative processes have been completed.
NTRB Ratings Summary
NTRB Quant Ranking